RETA20 — Retatrutide 20mg
Triple receptor agonist targeting GLP-1, GIP, and glucagon receptors for advanced metabolic research.
What is RETA20?
Retatrutide (RETA20) is a novel triple receptor agonist that simultaneously targets three key metabolic receptors: glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors. This tri-agonist profile makes it one of the most advanced research compounds available for metabolic pathway investigation.
Key Features
- Simultaneous activation of three metabolic receptor pathways
- High purity ≥98% verified by RP-HPLC and mass spectrometry
- Lyophilised for maximum stability and shelf life
- Batch-specific Certificate of Analysis included
Mechanism of Action
By activating GLP-1 receptors, Retatrutide modulates insulin secretion and gastric emptying. GIP receptor activation enhances insulin sensitivity and lipid metabolism. Glucagon receptor agonism increases energy expenditure and hepatic glucose output. The combined action of all three pathways creates a synergistic effect on metabolic regulation that researchers are actively investigating.
Research Applications
- Metabolic syndrome pathway investigation
- Adipose tissue regulation studies
- Insulin sensitivity and glucose homeostasis research
- Energy expenditure and thermogenesis studies
- Comparative receptor pharmacology
Reconstitution Guide
Reconstitute with sterile bacteriostatic water (BAC Water). Add solvent slowly down the side of the vial. Gently swirl — do not shake. Store reconstituted solution at 2–8°C and use within 28 days.
Research Use Only. For research use only. Not for human or veterinary use. Not for sale to the general public. All products are intended solely for in vitro research and laboratory use. Helix Biotech does not endorse, encourage, or condone the use of any research compounds in humans or animals.
Research Tools
Related Products
View all
MS40 — MOTS-C
Mitochondria-derived peptide for advanced metabolic and cellular energy research.
NJ250 — NAD+ 250mg
Nicotinamide Adenine Dinucleotide — 250mg cellular energy and longevity research compound.
AOD9604 5mg
Fragment 176-191 of human growth hormone — research peptide for fat metabolism studies.